Internal Medicine, Endocrinology, Diabetes, & Metabolism · Grand Rapids, MI
NPI
1912948233
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
221 Michigan St NE Ste 200
Grand Rapids, MI, 49503
Phone (616) 267-8950
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
596 services
Medicare patients, 2024
404
Average age 70
Drug cost, 2024
$1.2M
5,200 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward Kryshak was code 99213 (office e&m - established), 417 times for 329 patients. In total Edward Kryshak billed 596 services in 7 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 417 | 329 | $59.22 | $25K |
| 99204 Office E&M - New | Office | 81 | 81 | $100.29 | $8,124 |
| 95251 Test - Miscellaneous | Office | 65 | 53 | $26.65 | $1,732 |
| 99214 Office E&M - Established | Office | 17 | 16 | $86.24 | $1,466 |
By year: 2022 $40K for 552 services; 2023 $35K for 500 services; 2024 $39K for 596 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward Kryshak prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,660 prescriptions and refills. In total Edward Kryshak wrote 5,200 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,660 | 4,729 | 514 | $33K |
| Methimazole Generic | 220 | 620 | 77 | $4,552 |
| Alendronate Sodium Generic | 162 | 434 | 57 | $2,334 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 157 | 384 | 60 | $26K |
| Metformin Hcl Er Metformin Hcl | 141 | 413 | 54 | $3,071 |
| Humalog Kwikpen U-100 Insulin Lispro | 140 | 313 | 57 | $52K |
| Atorvastatin Calcium Generic | 134 | 364 | 46 | $1,926 |
| Metformin Hcl Generic | 106 | 303 | 39 | $3,153 |
| Mounjaro Tirzepatide | 103 | 103 | 33 | $105K |
| Glimepiride Generic | 100 | 261 | 38 | $1,959 |
| Synthroid Levothyroxine Sodium | 95 | 282 | 28 | $12K |
| Hydrocortisone Generic | 92 | 177 | 25 | $5,135 |
| Jardiance Empagliflozin | 88 | 190 | 28 | $100K |
| Trulicity Dulaglutide | 84 | 143 | 33 | $134K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 75 | 168 | 31 | $65K |
Brand drugs: 2,269 claims; generic drugs: 2,661 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward Kryshak $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.